[1]
«An Open Label Clinical Study Evaluating the Effectiveness of a Cryptolepis sanguinolenta based Herbal Antimalarial Agent», AJBR, vol. 22, n.º 3, pp. 257–262, dez. 2019, Acedido: 7 de abril de 2026. [Online]. Disponível em: https://www.ojshostng.com/index.php/ajbr/article/view/1321